Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5807)
All Articles published online
|
Publishing Process of This Article
|
Sep 7, 2014 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Yang J, Zhou Y, Min K, Yao Q, Xu CN. S-1-based |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i33/11886.htm |
| Number | Citing Articles |
| 1 |
Jinping Sun, Zheng Ren, Xinfang Sun, Hongtao Hou, Ke Li, Quanxing Ge. Efficacy and safety comparison of chemotherapies for advanced gastric cancer: A network meta-analysis. Oncotarget 2017; 8(24): 39673 doi: 10.18632/oncotarget.17784
|
| 2 |
Emil ter Veer, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven. The Use of (Network) Meta-Analysis in Clinical Oncology. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00822
|
| 3 |
Kimihiko Funahashi, Tetsuo Nemoto, Junichi Koike, Akiharu Kurihara, Hiroyuki Shiokawa, Mistunori Ushigome, Tomoaki Kaneko, Kenichiro Arai, Yasuo Nagashima, Takamaru Koda, Takayuki Suzuki, Satoru Kagami, Yu Suitsu, Hironori Kaneko, Toshikazu Shibuya. Chemoradiation therapy with S-1 for primary squamous cell carcinoma of the rectum: report of three cases. Surgical Case Reports 2015; 1(1) doi: 10.1186/s40792-015-0025-5
|
| 4 |
Lei Yang, Xingcheng Wang, Binsheng Wang, Peng Chao, Debang Li, Chen Chai. The clinical outcomes of S-1 plus cisplatin for patients with advanced gastric cancer. Medicine 2018; 97(49): e12789 doi: 10.1097/MD.0000000000012789
|
| 5 |
Emil ter Veer, Nadia Haj Mohammad, Paul Lodder, Lok Lam Ngai, Mary Samaan, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven. The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis. Gastric Cancer 2016; 19(3): 696 doi: 10.1007/s10120-015-0587-8
|
| 6 |
Omar Abdel-Rahman, Hesham ElHalawani, Shaimaa Essam-Eldin. S-1-based regimens and the risk of leucopenic complications; a Meta-analysis with comparison to other fluoropyrimidines and non fluoropyrimidines. Expert Opinion on Drug Safety 2016; 15(4): 437 doi: 10.1517/14740338.2016.1146674
|
| 7 |
Markus Moehler, Rolf Mahlberg, Volker Heinemann, Radka Obermannová, Eugen Kubala, Bohuslav Melichar, Arndt Weinmann, Paul Scigalla, Marietta Tesařová, Petr Janda, Fabienne Hédouin-Biville, Wasat Mansoor. Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naïve advanced or metastatic esophagogastric cancer. Gastric Cancer 2017; 20(2): 358 doi: 10.1007/s10120-016-0618-0
|
| 8 |
Linda Agolli, Luca Nicosia. Between evidence and new perspectives on the current state of the multimodal approach to gastric cancer: Is there still a role for radiation therapy?. World Journal of Gastrointestinal Oncology 2018; 10(9): 271-281 doi: 10.4251/wjgo.v10.i9.271
|
| 9 |
Xiaolong Qi, Yanna Liu, Wei Wang, Danxian Cai, Wende Li, Jialiang Hui, Chuan Liu, Yanxia Zhao, Guoxin Li. Management of advanced gastric cancer: An overview of major findings from meta-analysis. Oncotarget 2016; 7(47): 78180 doi: 10.18632/oncotarget.12102
|
| 10 |
Fang-Lan Wu, De-Cheng Lu, Yan-Ping Ying, Jin-Jiao Huang, Ai-Min Zhou, Dun-Ke Jiang, Mao-Wei Chen, Xi Yang, Jia Zhou, Hui-Qiao Huang, Hong-Yan Zeng. A Meta-analysis Reveals S-1-based Chemotherapy Improves the Survival of Patients With Advanced Gastric Cancer. Medicine 2015; 94(16): e652 doi: 10.1097/MD.0000000000000652
|
| 11 |
Ning-ning Bian, Yong-hong Wang, Guang-tao Min. S-1 combined with paclitaxel may benefit advanced gastric cancer: Evidence from a systematic review and meta-analysis. International Journal of Surgery 2019; 62: 34 doi: 10.1016/j.ijsu.2018.11.010
|
| 12 |
Purvish M Parikh, Tarini P. Sahoo, Ghanashyam Biswas, Vineet Talwar, Somashekhar SP, Soumya Surath Panda, Avinash CB, Nishita Shetty, Anita Ramesh, Joydeep Ghosh, Vijith Vital Shetty, Radheshyam Naik, Ashish Singh, Gaurav Gupta, Bhavesh Parekh. Practical Consensus Guidelines for the Use of S-1 in GI Malignancies. South Asian Journal of Cancer 2024; doi: 10.1055/s-0043-1778685
|
| 13 |
Emil ter Veer, Aafke Creemers, Laura de Waal, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven. Comparing cytotoxic backbones for first‐line trastuzumab‐containing regimens in human epidermal growth factor receptor 2‐positive advanced oesophagogastric cancer: A meta‐analysis. International Journal of Cancer 2018; 143(2): 438 doi: 10.1002/ijc.31325
|
| 14 |
Qingqing Hu, Jiajia Xu, Jingshu Ke, Ziye Zhang, Ting Chu, Sherief Ghozy. S-1 and 5-Fluorouracil-related adverse events in patients with advanced gastric cancer: A meta-analysis. PLOS ONE 2023; 18(8): e0290003 doi: 10.1371/journal.pone.0290003
|
| 15 |
Yan Liu, Changchun Zhou, Kai Zhang, Yikuan Feng, Ruihua Zhang. The combination of apatinib and S-1 for the treatment of advanced gastric cancer in China. Medicine 2018; 97(47): e13259 doi: 10.1097/MD.0000000000013259
|
| 16 |
Lucheng Zhu, Jihong Liu, Shenglin MA. Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Gastric Cancer: a Bayesian Network Meta-Analysis. Pathology & Oncology Research 2016; 22(4): 853 doi: 10.1007/s12253-016-0078-1
|
| 17 |
Luchun Li, Ting Wang, Zhijuan Wu, Yan Li, Huiwen Ma, Lulu Wang, Shuangyi Lei. S-1 maintenance therapy in advanced gastric cancer without disease progression after first-line chemotherapy: A retrospective analysis. Science Progress 2023; 106(4) doi: 10.1177/00368504231212792
|
| 18 |
György Bodoky, Max E. Scheulen, Fernando Rivera, Jacek Jassem, Alfredo Carrato, Vladimir Moiseyenko, Ihor Vynnychenko, Jana Prausová, Jean-Luc Van Laethem, Stefano Cascinu, Jaffer A. Ajani. Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS). Journal of Gastrointestinal Cancer 2015; 46(2): 109 doi: 10.1007/s12029-014-9680-1
|
| 19 |
Kohei Shitara, Toshihiko Doi, Mikhail Dvorkin, Wasat Mansoor, Hendrik-Tobias Arkenau, Aliaksandr Prokharau, Maria Alsina, Michele Ghidini, Catia Faustino, Vera Gorbunova, Edvard Zhavrid, Kazuhiro Nishikawa, Ayumu Hosokawa, Şuayib Yalçın, Kazumasa Fujitani, Giordano D Beretta, Eric Van Cutsem, Robert E Winkler, Lukas Makris, David H Ilson, Josep Tabernero. Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Oncology 2018; 19(11): 1437 doi: 10.1016/S1470-2045(18)30739-3
|
| 20 |
Akimitsu Iizuka, Mitsuro Kanda, Seiji Ito, Yoshinari Mochizuki, Hitoshi Teramoto, Kiyoshi Ishigure, Toshifumi Murai, Takahiro Asada, Akiharu Ishiyama, Hidenobu Matsushita, Chie Tanaka, Daisuke Kobayashi, Michitaka Fujiwara, Kenta Murotani, Yasuhiro Kodera. Proposal of a Scoring Scale to Estimate Risk of the Discontinuation of S‐1 Adjuvant Monotherapy in Patients with Stage II to III Gastric Cancer: A Multi‐Institutional Dataset Analysis. World Journal of Surgery 2019; 43(8): 2016 doi: 10.1007/s00268-019-04942-y
|
| 21 |
S.M.Zeeshan Qadar, Zhiyong Dong, Sheikh Mohammed Shariful Islam, Jianxue Wang, Xiling Xu, Fakhsheena Anjum, Sana Shamim, Bafreen Sherif, Sundas Ali. S-1 plus oxaloplatin (S-1OX) versus capecitabine plus oxaloplatin (CAPOX) for advanced gastric cancer: A systematic review and meta-analysis. Computer Methods and Programs in Biomedicine Update 2024; 5: 100151 doi: 10.1016/j.cmpbup.2024.100151
|